课题基金 / 基金详情

REGULATION OF EXPRESSION OF C-MYB IN LEUKEMIAS

REGULATION OF EXPRESSION OF C-MYB IN LEUKEMIAS
白血病中 C-MYB 表达的调节
批准号:
2733270
负责人:
LINDA M BOXER
金额:
$19.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-16 至 2001-06-30

项目摘要

项目成果

LINDA M BOXER的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(改编自研究者摘要)c-myb癌基因 在未成熟的造血细胞和许多 白血病 白血病细胞似乎对反义核酸更敏感, 抑制c-myb的表达比正常造血细胞。 虽然很明显白血病细胞需要增加c-myb的表达 对于增殖来说,导致这种增殖的分子机制增加了, 表达是未知的。 本提案的目的是确定 负责转录控制的分子机制 c-myb基因在正常和恶性造血细胞中的表达。 1. 基因转录调控的分子机制 正常T细胞中的c-myb。 T细胞活化导致表达增加 c-myb mRNA。 他们将进行体内足迹,体外蛋白质-DNA 结合研究和瞬时转染实验来研究 c-myb基因的转录调控。 2. 识别 白血病细胞c-myb转录调控的分子机制 目标1中所述的研究将对白血病样本进行, 表达高水平的c-myb mRNA,细胞系将用于 瞬时转染实验。 在细胞中鉴定的调节蛋白 将白血病细胞与在正常T细胞中鉴定的那些进行比较。 3. 第一内含子在c-myb转录调控中的作用。 他们有 表明第一内含子中存在正调控区。 他们 我将继续研究这一点,并调查它在 白血病细胞 他们还将决定是否阻止转录 延伸是在第一个内含子或转录起始位点。 4. c-myb基因甲基化状态的测定。 CpG的甲基化 二核苷酸被认为参与基因沉默机制。 他们 将决定静止期和非静止期c-myb的甲基化状态, 在不表达c-myb的HeLa细胞和白血病细胞中, 细胞 有了这些信息,他们希望发现c-myb表达是如何影响 并开始了解这是如何导致 恶性转化
英文摘要
DESCRIPTION: (adapted from the investigator's abstract) The c-myb oncogene is expressed at high levels in immature hematopoietic cells and in many leukemias. Leukemic cells appear to be more sensitive to antisense inhibition of c-myb expression than normal hematopoietic cells are. Although it is clear that leukemic cells require increased c-myb expression for proliferation, the molecular mechanisms that lead to this increased expression are not known. The goal of this proposal is to determine the molecular mechanisms responsible for the transcriptional control of the c-myb gene in both normal and malignant hematopoietic cells. 1. Identification of the molecular mechanisms of transcriptional control of c-myb in normal T cells. Activation of T cells causes increased expression of c-myb mRNA. They will perform in vivo footprinting, in vitro protein-DNA binding studies, and transient transfection experiments to study the transcriptional regulation of the c-myb gene. 2. Identification of the molecular mechanism of transcriptional control of c-myb in leukemic cells. Studies as described in Aim 1 will be performed on leukemic samples that express high levels of c-myb mRNA and cell lines will be used for the transient transfection experiments. The regulatory proteins identified in leukemic cells will be compared to those identified in normal T cells. 3. Role of the first intron in the transcriptional control of c-myb. They have shown that a positive regulatory region exists in the first intron. They will continue to study this and also investigate the role it plays in leukemic cells. They will also determine whether the block to transcription elongation is in the first intron or at the transcription start site. 4. Determination of the methylation status of c-myb. Methylation of CpG dinucleotides is thought to be involved in a gene silencing mechanism. They will determine the methylation status of c-myb in both quiescent and activated T cells, in HeLa cells which do not express c-myb, and in leukemic cells. With this information they hope to discover how c-myb expression is deregulated in leukemias and to begin to understand how this contributes to malignant transformation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Activation of BCL-2 in Hematologic Malgnancies
Training Program in Investigative Hematology
  • 批准号:
    7902054
  • 项目类别:
  • 资助金额:
    $9.91万
  • 财政年份:
    2001
  • 负责人:
    LINDA M BOXER
  • 依托单位:
Molecular Studies of Human All
  • 批准号:
    6360394
  • 项目类别:
  • 资助金额:
    $22.33万
  • 财政年份:
    2001
  • 负责人:
    LINDA M BOXER
  • 依托单位:
Training Program in Investigative Hematology
  • 批准号:
    6785381
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2001
  • 负责人:
    LINDA M BOXER
  • 依托单位:
海外基金